| Literature DB >> 32369954 |
Janith Weerasinghe1,2, Wenshao Li3, Rusen Zhou4, Renwu Zhou5, Alexander Gissibl3, Prashant Sonar1,2, Robert Speight3, Krasimir Vasilev6, Kostya Ken Ostrikov1,2.
Abstract
Silver nanoparticles have applications in plasmonics, medicine, catalysis and electronics. We report a simple, cost-effective, facile and reproducible technique to synthesise silver nanoparticles via plasma-induced non-equilibrium liquid chemistry with the absence of a chemical reducing agent. Silver nanoparticles with tuneable sizes from 5.4 to 17.8 nm are synthesised and characterised using Transmission Electron Microscopy (TEM) and other analytic techniques. A mechanism for silver nanoparticle formation is also proposed. The antibacterial activity of the silver nanoparticles was investigated with gram-positive and gram-negative bacteria. The inhibition of both bacteria types was observed. This is a promising alternative method for the instant synthesis of silver nanoparticles, instead of the conventional chemical reduction route, for numerous applications.Entities:
Keywords: AC – DBD plasma; plasma production of nanoparticles; silver nanoparticles
Year: 2020 PMID: 32369954 PMCID: PMC7279381 DOI: 10.3390/nano10050874
Source DB: PubMed Journal: Nanomaterials (Basel) ISSN: 2079-4991 Impact factor: 5.076
Figure 1Schematic diagram of the DBD plasma setup used for the Ag nanoparticles synthesis. Inset: detailed diagram of the DBD plasma system.
Figure 2Ultraviolet-visible (UV-Vis) spectra of the silver nanoparticles synthesised on different plasma exposure times (left); size distribution of Ag nanoparticles measured by the Dynamic Light Scattering (DLS) method technique for different plasma exposure times (right).
Variation of DLS size values on different exposure times of cold plasma.
| Plasma Exposure (min) | DLS (nm) | % Volume | Standard Deviation |
|---|---|---|---|
| 3 | 20.06 | 90.9 | 5.543 |
| 5 | 16.16 | 95.9 | 3.746 |
| 7 | 15.27 | 92.2 | 4.322 |
| 10 | 9.99 | 98.4 | 3.405 |
Figure 3Transmission Electron Microscopy (TEM) images of the nanoparticles synthesised under different plasma exposure times: (a) 3 min, (b) 5 min, (c) 7 min, (d) 10 min; size distribution of the nanoparticles determined from TEM: (e) 3 min, (f) 5 min, (g) 7 min, (h) 10 min; HRTEM of nanoparticles (i) 3 min, (j) 5 min, (k) 7 min, (l) 10 min.
Figure 4Treatment (plasma exposure time) time curves for (a) E. coli and (c) S. aureus. Example optical image of E. coli clearance zones (b) and S. aureus (d) on agar plates with different silver nanoparticle samples under visible light.
Figure 5OES spectrum of the Argon DBD plasma used to treat the precursor solution (left); schematic representation of the DBD plasma assisted silver nanoparticle formation (right).
Observed optical emission spectroscopy (OES) data of the argon emission spectral lines. Transition, initial energy levels (Ei) and final energy levels (Ef) taken from Ref [10].
| Wavelength (nm) | Transition | Relative Intensity (a.u) | Ei (eV) | Ef (eV) |
|---|---|---|---|---|
| 696 | 2p2 → 1s5 | 61,371 | 13.33 | 11.55 |
| 707 | 2p3 → 1s5 | 15,587 | 13.30 | 11.55 |
| 715 | 2p5 → 1s5 | 3284 | 13.28 | 11.55 |
| 727 | 2p2 → 1s4 | 26,821 | 13.33 | 11.62 |
| 738 | 2p3 → 1s4 | 30,896 | 13.30 | 11.62 |
| 750 | 2p1 → 1s2 | 55,719 | 13.48 | 11.83 |
| 751 | 2p5 → 1s4 | 36,434 | 13.27 | 11.62 |
| 763 | 2p6 → 1s5 | 65,549 | 13.17 | 11.55 |
| 772 | 2p2 → 1s3 | 65,450 | 13.15 | 11.55 |
| 795 | 2p4 → 1s3 | 57,756 | 13.28 | 11.72 |
| 801 | 2p6 → 1s4 | 48,875 | 13.09 | 11.55 |
| 810 | 2p7 → 1s4 | 50,477 | 13.15 | 11.62 |
| 811 | 2p9 → 1s5 | 62,028 | 13.08 | 11.55 |
| 826 | 2p2 → 1s2 | 61,613 | 13.33 | 11.83 |
| 841 | 2p3 → 1s2 | 27,474 | 13.30 | 11.83 |
| 842 | 2p8 → 1s4 | 61,277 | 13.09 | 11.62 |
| 852 | 2p4 → 1s2 | 18,474 | 13.28 | 11.83 |